Download Report

Bispecific antibodies with native chain structure 11.03.2014 Kristin Fritsch

Bispecific antibodies with native chain structure 11.03.2014 Kristin Fritsch

Biologic Properties of Bispecific Single-Chain Antibody Against 17-1A and CD3

Biologic Properties of Bispecific Single-Chain Antibody Against 17-1A and CD3

Monoclonal Antibodies as a novel class of cancer therapeutics

Monoclonal Antibodies as a novel class of cancer therapeutics

Document 940

Document 940

First-in-Man Study of E-3810 VEGFR/FGFR Inhibitor in Solid Tumors

First-in-Man Study of E-3810 VEGFR/FGFR Inhibitor in Solid Tumors

Case Presentation Lindsay R. Rubin, D.O. Wyatt Eye Detroit, MI

Case Presentation Lindsay R. Rubin, D.O. Wyatt Eye Detroit, MI

1 The Current State and the Issues of Antibody Drugs Introduction

1 The Current State and the Issues of Antibody Drugs Introduction

Document 4388

Document 4388

X Tumor Immunity (Clynes) Cross-presentation The Good News/Bad News Story

X Tumor Immunity (Clynes) Cross-presentation The Good News/Bad News Story

Complement as effector system in cancer immunotherapy Paolo Macor, Francesco Tedesco ∗

Complement as effector system in cancer immunotherapy Paolo Macor, Francesco Tedesco ∗

Introduction to Diagnostic and Therapeutic Monoclonal Antibodies .::VOLUME 17, LESSON 1::.

Introduction to Diagnostic and Therapeutic Monoclonal Antibodies .::VOLUME 17, LESSON 1::.

Paraneoplastic Syndromes Associated with Anti-Hu Antibodies Horacio Senties-Madrid MD

Paraneoplastic Syndromes Associated with Anti-Hu Antibodies Horacio Senties-Madrid MD

© Copyright 2026